Search results for: Health Policy and Regulation
Filter search results
The Promise of Gene Therapies: Are We Ready?
1 April 2021
In a webinar held on 16 March 2021, Mary Harney, Annie Hubert and Simone Boselli joined OHE’s Adrian Towse to debate the issues surrounding the adoption of gene therapies. In…
Key Factors on How to Procure, Pay, Distribute and Use Vaccines for COVID-19: A European Perspective
1 May 2021
…the Phase III vaccines pipeline (as of November 2020) and the vaccines’ technical differences, pros and cons. We introduce a vaccine classification system based on efficacy thresholds (or guardrails) and…
It Takes Two to Tango: When do Conditional Reimbursement Risk-Sharing Schemes Work for Both Parties?
1 December 2021
…the resources involved, in both negotiating and monitoring the schemes, and in the collection and analysis of the data. Innovators are put off by the cost and effort involved in…
OHE Lunchtime Seminar and Webinar: The UK Biotech Sector and Brexit: Past Performance and Future Prospects
2 November 2017, 12:00am
…a visiting professor at the London School of Economics and head of industrial policy at Policy Exchange. He was formerly editor of the Financial Times (1980-1990) and a senior fellow…
Real World Evidence for Coverage Decisions: Opportunities and Challenges
3 January 2018
…on RWE for HTA assessments and payer coverage decisions – both initial decisions and reassessments – and the majority of the paper focuses on this. Acceptance of an expanded future…
News Release: Report on Patient Choice in the UK
4 June 2010
…operating as intended and has not so far acted as a lever to improve quality and increase competition. Since April 2008, patients in England have been able to choose treatment…
Incentives for R&D for New Antimicrobial Drugs
31 August 2011
…provide complementary incentives and share the burden, and to explore and resolve regulatory issues. Conservation efforts and access are global issues and so must draw in global actors. ‘Achieving multi-stakeholder…
Prescribing, Budgets and Fundholding in General Practice
10 January 1997
…criticised aspects of Conservative health policy. The scheme was introduced without prior appraisal and with minimal consultation. Being untested, no contemporary evidence was available on the potential costs or benefits…
Defining the Complementarity of Medical Research Across Sectors in the UK
11 March 2014
…OHE; Jonathan Grant from the King’s Policy Institute, King’s College London; and Marco Hafner from RAND Europe. For additional information, please contact Jon Sussex. OHE’s interest in knowledge spillover and…